Range Low Price High Price Comment
30 days $2.42 $3.12 Friday, 24th May 2024 TRVI stock ended at $2.50. This is 1.57% less than the trading day before Thursday, 23rd May 2024. During the day the stock fluctuated 5.79% from a day low at $2.42 to a day high of $2.56.
90 days $2.35 $3.95
52 weeks $0.97 $3.95

Historical Trevi Therapeutics Inc. prices

Date Open High Low Close Volume
Feb 07, 2024 $1.44 $1.49 $1.44 $1.47 102 880
Feb 06, 2024 $1.40 $1.47 $1.40 $1.46 86 157
Feb 05, 2024 $1.41 $1.47 $1.39 $1.40 173 575
Feb 02, 2024 $1.43 $1.48 $1.35 $1.39 185 732
Feb 01, 2024 $1.46 $1.47 $1.37 $1.39 93 389
Jan 31, 2024 $1.54 $1.54 $1.42 $1.42 84 307
Jan 30, 2024 $1.59 $1.61 $1.50 $1.52 43 441
Jan 29, 2024 $1.59 $1.63 $1.50 $1.59 134 323
Jan 26, 2024 $1.34 $1.64 $1.34 $1.56 444 386
Jan 25, 2024 $1.36 $1.38 $1.31 $1.33 99 811
Jan 24, 2024 $1.35 $1.38 $1.33 $1.34 99 234
Jan 23, 2024 $1.31 $1.36 $1.30 $1.35 170 445
Jan 22, 2024 $1.36 $1.37 $1.27 $1.31 241 978
Jan 19, 2024 $1.37 $1.39 $1.34 $1.35 104 922
Jan 18, 2024 $1.37 $1.39 $1.35 $1.36 81 303
Jan 17, 2024 $1.34 $1.36 $1.33 $1.35 156 512
Jan 16, 2024 $1.42 $1.47 $1.35 $1.36 139 359
Jan 12, 2024 $1.46 $1.54 $1.41 $1.42 127 468
Jan 11, 2024 $1.40 $1.48 $1.33 $1.46 200 939
Jan 10, 2024 $1.38 $1.43 $1.32 $1.33 200 138
Jan 09, 2024 $1.36 $1.39 $1.32 $1.35 134 762
Jan 08, 2024 $1.32 $1.40 $1.30 $1.36 116 719
Jan 05, 2024 $1.40 $1.43 $1.32 $1.32 157 766
Jan 04, 2024 $1.34 $1.41 $1.29 $1.38 148 322
Jan 03, 2024 $1.29 $1.37 $1.29 $1.31 227 477

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use TRVI stock historical prices to predict future price movements?
Trend Analysis: Examine the TRVI stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the TRVI stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About Trevi Therapeutics Inc.

Trevi Therapeutics. Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis. It has a license agreement with Endo P... TRVI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT